Friendly link：
All Rights Reserved Rhegen Bio Address：Nanshan, Shenzhen/Zhangjiang, Shanghai/Wuhan Guanggu
ICP：粤ICP备20034280号 ©2008-2025
With independent research and development, Rhegen Bio has established a technical platform covering the whole process, focusing on solving the pharmaceutical problem of mRNA and upgrading the success in clinical trials.
Our protein design platform can optimize the structure of target proteins to improve the half-life in vivo and enhance the immunogenicity of vaccines.
Rhegen Bio has developed a variety of methods for mRNA sequence optimization responding to different applications, which can improve the stability of mRNA and the efficiency of mRNA production, so as to achieve a long-term efficient expression of target proteins.
Rhegen Bio has established an advanced synthesis platform with higher efficiency and quality than other conventional methods. Chemical modifications can regulate the immunogenicity of mRNA and adapt to different application scenarios.
Rhegen Bio has been developing different mRNA delivery systems and deepening the patent layout in this field to accumulate a number of core patents. Our delivery system can deliver mRNA to specific organs or tissues, where mRNA can translate into proteins efficiently.
Wechat QR Code
All Rights Reserved Rhegen Bio Address：Nanshan, Shenzhen/Zhangjiang, Shanghai/Wuhan Guanggu
ICP：粤ICP备20034280号 ©2008-2025